Phospholipase A2 3D structures: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 50: | Line 50: | ||
**[[1faz]], [[1kp4]] – SvPLA2 – ''Streptomyces violaceruber''<br /> | **[[1faz]], [[1kp4]] – SvPLA2 – ''Streptomyces violaceruber''<br /> | ||
**[[1it4]], [[1it5]] – SvPLA2 – NMR<br /> | **[[1it4]], [[1it5]] – SvPLA2 – NMR<br /> | ||
**[[7m6cj]] - PLA2 – ''Bothrops atrox''<br /> | |||
**[[7ygkj]] - PLA2 – ''Sciscionella marina<''br /> | |||
*Phospholipase A2 group I | *Phospholipase A2 group I | ||
Line 86: | Line 88: | ||
**[[4rfp]] – PLA2 – chinese green tree viper | **[[4rfp]] – PLA2 – chinese green tree viper | ||
*PLA2 group VI | |||
**[[6aun]] – PLA2G6 – chinese hamster<br /> | |||
*Human phospholipase A2 group X | *Human phospholipase A2 group X | ||
Line 203: | Line 209: | ||
**[[3iq3]], [[2h8i]] – BTX + PEG<br /> | **[[3iq3]], [[2h8i]] – BTX + PEG<br /> | ||
**[[1z76]] – BTX+bromophenacyl<br /> | **[[1z76]] – BTX+bromophenacyl<br /> | ||
**[[7rox]] – BTX-I + inhibitor<br /> | |||
**[[2oqd]], [[3jr8]] – BTX-II<br /> | |||
**[[1gmz]], [[1qll]], [[2q2j]], [[2ok9]] - PTX<br /> | **[[1gmz]], [[1qll]], [[2q2j]], [[2ok9]] - PTX<br /> | ||
**[[3cyl]], [[3cxi]] – PTX+a-tocopherol<br /> | **[[3cyl]], [[3cxi]] – PTX+a-tocopherol<br /> | ||
**[[ | **[[8dnd]] – PTX-I + inhibitor<br /> | ||
**[[7m6cj]] - PLA2 – ''Bothrops atrox''<br /> | |||
*Viperotoxin | *Viperotoxin |
Latest revision as of 10:29, 28 August 2023
3D Structures of Phospholipase A23D Structures of Phospholipase A2
Updated on 28-August-2023
- Phospholipase A2 group V
- 4rfp – PLA2 – chinese green tree viper
- PLA2 group VI
- 6aun – PLA2G6 – chinese hamster
- 6aun – PLA2G6 – chinese hamster
- Human phospholipase A2 group X
- Human phospholipase A2 group XV
- Human phospholipase A2 group XVI
- Phospholipase A2 group XIII
- 4aup – PLA13 – whitish truffle
- Phospholipase A2 +inhibitor
- 1db4, 1db5, 1dcy – hPLA2+indole
- 1poe – hPLA2+phosphonyl inhibitor
- 1fdk – bPLA2+MJ33
- 1mkv – bPLA2+transition state analog
- 1o2e – bPLA2 (mutant)+anisic acid
- 2b96 - bPLA2+benzoic acid derivative
- 3bp2 – bPLA2+pyruvic acid
- 3o4m, 3hsw – pPLA2+inhibitor
- 2azy, 2azz, 2b00, 2b01, 2b03, 2b04 – pPLA2+cholate derivative
- 1y6o, 1fx9, 1fxf – pPLA2+MJ33
- 1l8s – pPLA2+LPC-ether
- 5p2p – pPLA2+substrate analog
- 3nju – PLA2 group I+4-methoxy-benzoic acid – Andaman cobra
- 2wq5 – PLA2+minocyclin – Indian cobra
- 1oxl – IcPLA2+indole
- 3h1x, 3fo7 – IvPLA2+indomethacin
- 3fg5 – IvPLA2+pentapeptide+ajmaline
- 3cbi – IvPLA2+anisic acid+ajmaline
- 2qu9 – IvPLA2+eugenol
- 2otf – IvPLA2+atenolol
- 1zwp - IvPLA2+nimesulide
- 1th6 - IvPLA2+atropine
- 1td7 - IvPLA2+niflumic acid
- 1tgm - IvPLA2+aspirin
- 2wg9 – rPLA2+octanoic acid
- 1oxr – NsPLA2+aspirin
- 1bk9 – AhPLA2+PBPB
- 1pob - NnPLA2+transition state analog
- 1poc - PLA2+transition state analog – Honey bee
- 1fv0 – DrPLA2+aristolochic acid
- 1sv3 - DrPLA2+benzoic acid derivative
- 1tp2, 2pws, 2q1p – DrPLA2+fatty acid
- 1sv9, 1sxk, 1zyx, 2b17, 2qvd – DrPLA2+anti-inflammatory agent
- 1kpm – DrPLA2+vitamin E
- 1oyf – DrPLA2+venom-6 methyl-heptanol
- 1q7a – DrPLA2+oxyphenabutazone
- 1y38 – DrPLA2+glycerophosphate
- 1zr8 – DrPLA2+ajmaline
- 2arm – DrPLA2+atropine
- 2dpz – DrPLA2 +hydroxyphenyl acetamide
- 2oli, 2oth, 2oyf – DrPLA2+indole derivative
- 2oub – DrPLA2+atenolol
- 4qem – DrPLA2 + coumaric acid
- 4qer – DrPLA2 + resveratrol
- 4qf7 – DrPLA2 + corticosterone
- 4qf8 – DrPLA2 + spermidine
- 4qgd – DrPLA2 + gramine derivative
- 4qmc – DrPLA2 + biotin derivative
- 2pmj – DrPLA2+benzopyrone
- 2zbh – DrPLA2+bavachalcone
- 4eix - DrPLA2+indomethacin + nimesulide
- 1po8, 1tc8 – kPLA2+fatty acid
- 1xxs – PLA2+fatty acid – Bothrops moojeni
- 2qhd – EcPLA2+fatty acid
- 3bjw – EcPLA2+suramin
- 1y4l – PLA2+suramin – Bothrops asper
- 1db4, 1db5, 1dcy – hPLA2+indole
- Phospholipase A2 +polypeptide
- Lp-PLA2
- Lp-PLA2 binary complexes
- 3dt9 - bLP-PLA2 α subunit (mutant) + soman
- 3d5e - hLP-PLA2 residues 47-429 + paraoxon
- 3f96 - hLP-PLA2 residues 47-429 + sarin
- 3f97 - hLP-PLA2 residues 47-429 + soman
- 3f98 - hLP-PLA2 residues 47-429 + tabun
- 3f9c - hLP-PLA2 residues 47-429 + DFP
- 5i8p, 5i9i, 5jad, 5jah, 5jal, 5jan, 5jao, 5jap, 5jar, 5jas, 5jat, 5jau, 5lp1, 5lz2, 5lz8, 5lz9 - hLP-PLA2 residues 47-429 + inhibitor
- 5lyy, 5lz4, 5lz5, 5lz7 - hLP-PLA2 residues 47-429 (mutant) + inhibitor
- 3dt6 - bLP-PLA2 α subunit (mutant) + paraoxon
- 3dt8 - bLP-PLA2 α subunit (mutant) + sarin
- 3dt9 - bLP-PLA2 α subunit (mutant) + soman
- 3dt9 - bLP-PLA2 α subunit (mutant) + soman
- Bothrops toxins
- Viperotoxin
- 1oqs – DrRV4/RV7
- cPhospholipase A2
- Pro-Phospholipase A2